Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. O-cymen-5-ol
1. 3228-02-2
2. 3-methyl-4-isopropylphenol
3. 4-isopropyl-m-cresol
4. O-cymen-5-ol
5. Biosol
6. 3-methyl-4-propan-2-ylphenol
7. P-thymol
8. Phenol, 3-methyl-4-(1-methylethyl)-
9. O-cymen-5y-ol
10. 4-isopropyl-5-methylphenol
11. 4-isopropyl-3-methyl-phenol
12. 1-hydroxy-3-methyl-4-isopropylbenzene
13. 3-methyl-4-(propan-2-yl)phenol
14. 3-methyl-4-(1-methylethyl)phenol
15. Mfcd00010704
16. H41b6q1i9l
17. Nsc-62111
18. Frecide
19. Biosal (antibacterial)
20. Isopropylmethylphenol
21. Einecs 221-761-7
22. Nsc 62111
23. Dekacymen
24. Brn 1364028
25. Unii-h41b6q1i9l
26. 2-cymen-5-ol
27. 4-iso-propyl-3-methylphenol
28. Cymen-5-ol, O-
29. Bidd:er0450
30. Schembl133674
31. O-cymen-5-ol [inci]
32. Chebi:34429
33. Ijalwsvnubbqra-uhfffaoysa-
34. Dtxsid10186026
35. O-cymen-5y-ol [who-dd]
36. 3-methyl-4-isopropylphenol, 99%
37. 4-i-propyl-3-methylphenol
38. 4-isopropyl-3-methylphenol, 99%
39. Amy18255
40. Nsc62111
41. Zinc1691011
42. Akos000119826
43. Ac-9076
44. Ds-6343
45. Bp-12478
46. Sy051849
47. 3-methyl-4-(propan-2-yl)benzolol
48. Db-048192
49. Cs-0072744
50. Ft-0618824
51. M0409
52. F17347
53. 4-06-00-03325 (beilstein Handbook Reference)
54. A821219
55. W-106848
56. Q27116059
57. F0001-0962
58. Z1262246127
Molecular Weight | 150.22 g/mol |
---|---|
Molecular Formula | C10H14O |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 1 |
Exact Mass | 150.104465066 g/mol |
Monoisotopic Mass | 150.104465066 g/mol |
Topological Polar Surface Area | 20.2 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 120 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A O-Cymen-5-Ol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of O-Cymen-5-Ol, including repackagers and relabelers. The FDA regulates O-Cymen-5-Ol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. O-Cymen-5-Ol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A O-Cymen-5-Ol supplier is an individual or a company that provides O-Cymen-5-Ol active pharmaceutical ingredient (API) or O-Cymen-5-Ol finished formulations upon request. The O-Cymen-5-Ol suppliers may include O-Cymen-5-Ol API manufacturers, exporters, distributors and traders.
O-Cymen-5-Ol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of O-Cymen-5-Ol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right O-Cymen-5-Ol GMP manufacturer or O-Cymen-5-Ol GMP API supplier for your needs.
A O-Cymen-5-Ol CoA (Certificate of Analysis) is a formal document that attests to O-Cymen-5-Ol's compliance with O-Cymen-5-Ol specifications and serves as a tool for batch-level quality control.
O-Cymen-5-Ol CoA mostly includes findings from lab analyses of a specific batch. For each O-Cymen-5-Ol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
O-Cymen-5-Ol may be tested according to a variety of international standards, such as European Pharmacopoeia (O-Cymen-5-Ol EP), O-Cymen-5-Ol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (O-Cymen-5-Ol USP).
LOOKING FOR A SUPPLIER?